Institute of Molecular Cancer Research, University of Zurich, CH-8057 Zurich, Switzerland.
J Cell Biol. 2013 Mar 18;200(6):699-708. doi: 10.1083/jcb.201212058. Epub 2013 Mar 11.
Oncogene-induced DNA replication stress activates the DNA damage response (DDR), a crucial anticancer barrier. DDR inactivation in these conditions promotes genome instability and tumor progression, but the underlying molecular mechanisms are elusive. We found that overexpression of both Cyclin E and Cdc25A rapidly slowed down replication forks and induced fork reversal, suggestive of increased topological stress. Surprisingly, these phenotypes, per se, are neither associated with chromosomal breakage nor with significant DDR activation. Oncogene-induced DNA breakage and DDR activation instead occurred upon persistent G2/M arrest or, in a checkpoint-defective context, upon premature CDK1 activation. Depletion of MUS81, a cell cycle-regulated nuclease, markedly limited chromosomal breakage and led to further accumulation of reversed forks. We propose that nucleolytic processing of unusual replication intermediates mediates oncogene-induced genotoxicity and that limiting such processing to mitosis is a central anti-tumorigenic function of the DNA damage checkpoints.
癌基因诱导的 DNA 复制应激激活了 DNA 损伤反应(DDR),这是一种重要的抗癌屏障。在这些条件下 DDR 的失活会促进基因组不稳定性和肿瘤进展,但潜在的分子机制尚不清楚。我们发现,Cyclin E 和 Cdc25A 的过表达会迅速减缓复制叉的速度并诱导叉反转,提示拓扑学压力增加。令人惊讶的是,这些表型本身既与染色体断裂无关,也与明显的 DDR 激活无关。相反,癌基因诱导的 DNA 断裂和 DDR 激活发生在持续的 G2/M 期阻滞时,或者在 checkpoint 缺陷的情况下,发生在 CDK1 过早激活时。细胞周期调控核酸酶 MUS81 的耗竭显著限制了染色体断裂,并导致更多的反转叉积累。我们提出,异常复制中间体的核酶处理介导了癌基因诱导的遗传毒性,而将这种处理限制在有丝分裂中是 DNA 损伤检查点的一个主要抗肿瘤功能。